HEADER PROTEIN BINDING 19-DEC-19 6LKF TITLE SOLUTION STRUCTURE OF ANTI-CRISPR PROTEIN ACRIIA5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACRIIA5; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PHAGE D4276; SOURCE 3 ORGANISM_TAXID: 2006928; SOURCE 4 GENE: D4276_028; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.Y.AN,E.BAE,J.Y.SUH REVDAT 5 15-MAY-24 6LKF 1 REMARK REVDAT 4 14-JUN-23 6LKF 1 REMARK REVDAT 3 29-JUL-20 6LKF 1 JRNL REVDAT 2 01-JUL-20 6LKF 1 JRNL REVDAT 1 10-JUN-20 6LKF 0 JRNL AUTH S.Y.AN,D.KA,I.KIM,E.H.KIM,N.K.KIM,E.BAE,J.Y.SUH JRNL TITL INTRINSIC DISORDER IS ESSENTIAL FOR CAS9 INHIBITION OF JRNL TITL 2 ANTI-CRISPR ACRIIA5. JRNL REF NUCLEIC ACIDS RES. V. 48 7584 2020 JRNL REFN ESSN 1362-4962 JRNL PMID 32544231 JRNL DOI 10.1093/NAR/GKAA512 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6LKF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-DEC-19. REMARK 100 THE DEPOSITION ID IS D_1300014965. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 500 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.6 MM [U-13C; U-15N] ACRIIA5, REMARK 210 20 MM TRIS, 500 MM NACL, 90% H2O/ REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCACB; 3D CBCA(CO)NH; 3D 1H REMARK 210 -15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : PIPP REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 6 -105.21 12.13 REMARK 500 1 ASP A 50 74.10 -3.30 REMARK 500 1 ASN A 65 -164.17 -61.05 REMARK 500 1 ASN A 121 151.38 -42.75 REMARK 500 1 PHE A 133 116.23 -162.50 REMARK 500 1 LYS A 134 164.47 174.02 REMARK 500 2 ARG A 7 -31.14 71.91 REMARK 500 2 ARG A 12 168.06 51.04 REMARK 500 2 PHE A 16 57.17 -101.00 REMARK 500 2 ASN A 20 -121.92 41.82 REMARK 500 2 LYS A 21 -25.61 171.60 REMARK 500 2 ASP A 50 72.83 -2.24 REMARK 500 2 ASN A 65 -144.55 -55.40 REMARK 500 2 ASN A 121 174.24 -41.95 REMARK 500 2 PHE A 133 115.37 -162.40 REMARK 500 2 LYS A 134 164.89 174.58 REMARK 500 3 SER A 6 -156.70 64.23 REMARK 500 3 TYR A 8 63.47 -167.35 REMARK 500 3 ARG A 12 37.89 79.57 REMARK 500 3 PHE A 16 177.92 71.47 REMARK 500 3 ARG A 18 -137.86 69.82 REMARK 500 3 LYS A 49 54.46 -140.25 REMARK 500 3 ASP A 50 86.12 -17.81 REMARK 500 3 ASN A 65 -161.87 -57.82 REMARK 500 3 ASN A 121 150.57 -38.41 REMARK 500 3 PHE A 133 115.72 -161.89 REMARK 500 3 LYS A 134 163.99 173.13 REMARK 500 4 SER A 6 -149.48 64.46 REMARK 500 4 SER A 10 -156.52 44.26 REMARK 500 4 SER A 15 174.87 77.32 REMARK 500 4 ARG A 18 -159.31 67.49 REMARK 500 4 ASP A 50 69.55 0.56 REMARK 500 4 ASN A 65 -175.82 -69.25 REMARK 500 4 ASN A 121 171.05 -39.55 REMARK 500 4 PHE A 133 115.90 -162.39 REMARK 500 4 LYS A 134 164.88 175.39 REMARK 500 5 SER A 6 38.96 -150.93 REMARK 500 5 TYR A 8 64.16 93.26 REMARK 500 5 SER A 19 -143.24 68.43 REMARK 500 5 ASP A 50 79.28 -10.36 REMARK 500 5 ASN A 65 -168.86 -76.62 REMARK 500 5 LEU A 75 99.74 168.01 REMARK 500 5 ASN A 121 171.71 -39.97 REMARK 500 5 PHE A 133 116.16 -162.01 REMARK 500 5 LYS A 134 160.44 174.36 REMARK 500 6 TYR A 3 -71.70 57.80 REMARK 500 6 LYS A 13 -161.81 46.37 REMARK 500 6 ASN A 17 -135.21 44.97 REMARK 500 6 SER A 19 179.11 56.13 REMARK 500 6 GLN A 22 63.30 60.07 REMARK 500 REMARK 500 THIS ENTRY HAS 174 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 36303 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF ANTI-CRISPR PROTEIN ACRIIA5 DBREF1 6LKF A 1 140 UNP A0A220GHA5_9CAUD DBREF2 6LKF A A0A220GHA5 1 140 SEQRES 1 A 140 MET ALA TYR GLY LYS SER ARG TYR ASN SER TYR ARG LYS SEQRES 2 A 140 ARG SER PHE ASN ARG SER ASN LYS GLN ARG ARG GLU TYR SEQRES 3 A 140 ALA GLN GLU MET ASP ARG LEU GLU LYS ALA PHE GLU ASN SEQRES 4 A 140 LEU ASP GLY TRP TYR LEU SER SER MET LYS ASP SER ALA SEQRES 5 A 140 TYR LYS ASP PHE GLY LYS TYR GLU ILE ARG LEU SER ASN SEQRES 6 A 140 HIS SER ALA ASP ASN LYS TYR HIS ASP LEU GLU ASN GLY SEQRES 7 A 140 ARG LEU ILE VAL ASN ILE LYS ALA SER LYS LEU ASN PHE SEQRES 8 A 140 VAL ASP ILE ILE GLU ASN LYS LEU ASP LYS ILE ILE GLU SEQRES 9 A 140 LYS ILE ASP LYS LEU ASP LEU ASP LYS TYR ARG PHE ILE SEQRES 10 A 140 ASN ALA THR ASN LEU GLU HIS ASP ILE LYS CYS TYR TYR SEQRES 11 A 140 LYS GLY PHE LYS THR LYS LYS GLU VAL ILE HELIX 1 AA1 GLN A 22 ASN A 39 1 18 HELIX 2 AA2 ASN A 90 LEU A 109 1 20 HELIX 3 AA3 ASP A 110 TYR A 114 5 5 SHEET 1 AA1 7 TRP A 43 SER A 46 0 SHEET 2 AA1 7 SER A 51 ASP A 55 -1 O TYR A 53 N TYR A 44 SHEET 3 AA1 7 GLU A 60 SER A 64 -1 O LEU A 63 N ALA A 52 SHEET 4 AA1 7 ILE A 81 LYS A 85 1 O ILE A 84 N SER A 64 SHEET 5 AA1 7 PHE A 116 ALA A 119 1 O ALA A 119 N ASN A 83 SHEET 6 AA1 7 ILE A 126 TYR A 129 -1 O TYR A 129 N PHE A 116 SHEET 7 AA1 7 LYS A 137 ILE A 140 -1 O GLU A 138 N CYS A 128 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1